Products

Calcium Bioavailability: A Comparative Study of Different ...
In this article, researchers review the findings of a study on the bioavailability of different ... read more
The Expanding Role of Effervescent Technology
This article explains the benefits and applications of effervescent technology in solid dosage forms... read more
IPEC-Americas Celebrates 30 Years
The International Pharmaceutical Excipients Council of the Americas (IPEC-Americas) was formed 30 ... read more

View More Featured Articles »

Vegetarian Capsules Market Sees Global Growth
The global vegetarian capsules market is anticipated to grow at a considerable CAGR during the ... read more
JAMP Pharma Issues Recall of One Lot of Atorvastatin Tablets
JAMP Pharma Corporation is voluntarily recalling one product lot of Atorvastatin tablets, 40 mg, 100... read more
Mason Vitamins Issues Recall Over Labeling Concerns
Mason Vitamins has issued a nationwide voluntary recall of the specific lot of Healthy Sense Daily ... read more
ANI Pharmaceuticals, Inc. announced that the Company ...
ANI Pharmaceuticals, Inc. announced that the Company received FDA approval for the Abbreviated New ... read more
Toxoplasmosis Treatment on the Rise
The global toxoplasmosis treatment industry generated $683.1M in 2021, and is anticipated to ... read more
Nutraceuticals Start-Up Debuts Offers Whole-Cell Cultivated ...
Novella, Ltd. Has unveiled prototypes of its new line of berry-derived bioactives. The company is in... read more
Report: Cardiovascular Disease Prevalence in Developing ...
The prevalence and incidence of cardiovascular conditions in developed economies continue to ... read more
Tillotts Pharma Launches Ulcerative Colitis Treatment in ...
Tillotts Pharma AG, part of the Japanese Zeria Group, launched Octasa® 800mg (mesalazine) delayed-... read more
Sanofi Bets $1.53B on Sino Biopharm Oral JAK/ROCK Inhibitor
The drug is approved in China as treatment for myelofibrosis, but Sanofi wants to explore its ... read more
Phase 3 Results for Upadacitinib (RINVOQ®) in Ulcerative ...
AbbVie announced results from three Phase 3 clinical trials – U-ACHIEVE (induction), U-ACCOMPLISH ... read more

View More Featured News »

Featured Articles

Find Products Here

Featured Articles

Featured News